Pharma & Biotech Moderna given $176 million to develop mRNA vaccine against pandemic influenza By Proactive 05/07/2024
Battery Metals Copper outlook looks positive as iron ore shows signs of life despite volatility By Proactive 05/07/2024
Retail & consumer Australian market ends FY24 on a high; which sectors stood out? By Proactive 03/07/2024
Real Estate Lloyd’s of London chair rallies against Shard-sized City skyscraper By Proactive 02/07/2024
Retail & consumer Three things to watch for week ahead: RBA Minutes; Jerome Powell; retail sales By Proactive 01/07/2024
Investments and investor services Frank Talk: Bitcoin could hit $1M within a decade By Proactive 28/06/2024
Archive UK's stronger GDP good news for government, but might give BoE more pause By Proactive 28/06/2024
Energy Navigating Inflation: is it time to consider commodity-related stocks on ASX? By Proactive 28/06/2024
Health Moderna fields positive Phase 3 results for combination influenza and COVID-19 vaccine By Proactive 26/06/2024
Finance US markets present robust opportunities for Australian investors despite economic concerns By Proactive 26/06/2024
